• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尼帕病毒@20:具有大流行潜力的另一种病毒带来的教训。

Nipah@20: Lessons Learned from Another Virus with Pandemic Potential.

机构信息

Coalition for Epidemic Preparedness and Innovations (CEPI), Oslo, Norway

Duke-NUS Medical School, Singapore.

出版信息

mSphere. 2020 Jul 8;5(4):e00602-20. doi: 10.1128/mSphere.00602-20.

DOI:10.1128/mSphere.00602-20
PMID:32641430
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7343983/
Abstract

Nipah disease is listed as one of the WHO priority diseases that pose the greatest public health risk due to their epidemic potential. More than 200 experts from around the world convened in Singapore last year to mark the 20th anniversary of the first Nipah virus outbreaks in Malaysia and Singapore. Most of these experts are now involved in responding to the coronavirus disease 2019 (COVID-19) pandemic. Here, members of the Organizing Committee of the 2019 Nipah Virus International Conference review highlights from the Nipah@20 Conference and reflect on key lessons learned from Nipah that could be applied to the understanding of the COVID-19 pandemic and to preparedness against future emerging infectious diseases (EIDs) of pandemic potential.

摘要

尼帕病被世界卫生组织列为对公众健康构成最大威胁的优先疾病之一,因为它们具有流行潜力。去年,来自世界各地的 200 多名专家在新加坡聚会,纪念马来西亚和新加坡首次爆发尼帕病毒 20 周年。这些专家大多现在都在参与应对 2019 冠状病毒病(COVID-19)大流行。在这里,2019 年尼帕病毒国际会议组织委员会的成员回顾了尼帕@20 会议的重点,并思考了从尼帕病中吸取的关键经验教训,这些经验教训可以应用于对 COVID-19 大流行的理解,以及为未来具有大流行潜力的新发传染病(EID)做好准备。

相似文献

1
Nipah@20: Lessons Learned from Another Virus with Pandemic Potential.尼帕病毒@20:具有大流行潜力的另一种病毒带来的教训。
mSphere. 2020 Jul 8;5(4):e00602-20. doi: 10.1128/mSphere.00602-20.
2
Advances in diagnostics, vaccines and therapeutics for Nipah virus.尼帕病毒诊断、疫苗和治疗方法的进展。
Microbes Infect. 2019 Aug-Sep;21(7):278-286. doi: 10.1016/j.micinf.2019.02.002. Epub 2019 Feb 26.
3
Contact tracing: a lesson from the Nipah virus in the time of COVID-19.接触者追踪:新冠疫情期间尼帕病毒带来的教训。
Trop Doct. 2020 Jul;50(3):174-175. doi: 10.1177/0049475520928217. Epub 2020 May 31.
4
Singapore COVID-19 Pandemic Response as a Successful Model Framework for Low-Resource Health Care Settings in Africa?新加坡的 COVID-19 疫情应对能否成为非洲资源匮乏的医疗保健环境的成功模式框架?
OMICS. 2020 Aug;24(8):470-478. doi: 10.1089/omi.2020.0077. Epub 2020 Jun 16.
5
Nipah virus.尼帕病毒
Wkly Epidemiol Rec. 2004 Feb 27;79(9):86-8.
6
The Coronavirus Pandemic - Lessons Learned?新冠疫情——吸取的教训?
Am J Med Sci. 2020 Sep;360(3):313. doi: 10.1016/j.amjms.2020.06.002. Epub 2020 Jun 3.
7
Nipah virus, an emerging zoonotic disease causing fatal encephalitis.尼帕病毒,一种新兴的人畜共患疾病,可导致致命脑炎。
Clin Med (Lond). 2022 Jul;22(4):348-352. doi: 10.7861/clinmed.2022-0166. Epub 2022 Jun 27.
8
From Hendra to Wuhan: what has been learned in responding to emerging zoonotic viruses.从亨德拉病毒到武汉疫情:应对新出现的人畜共患病毒的经验教训
Lancet. 2020 Feb 22;395(10224):e33-e34. doi: 10.1016/S0140-6736(20)30350-0. Epub 2020 Feb 11.
9
Lessons learned from Korea: COVID-19 pandemic.从韩国汲取的经验教训:新冠疫情
Infect Control Hosp Epidemiol. 2020 Jul;41(7):873-874. doi: 10.1017/ice.2020.104. Epub 2020 Apr 3.
10
[Implications of the COVID-19 pandemic for cancer in Spain].[新冠疫情对西班牙癌症的影响]
Med Clin (Barc). 2020 Sep 25;155(6):263-266. doi: 10.1016/j.medcli.2020.04.011. Epub 2020 May 8.

引用本文的文献

1
Trafficking and Activation of , and Henipa-like Virus Fusion Proteins.亨尼帕样病毒融合蛋白的运输与激活
Viruses. 2025 Jun 19;17(6):866. doi: 10.3390/v17060866.
2
Nipah virus: Preventing the next outbreak.尼帕病毒:预防下一次疫情爆发。
World J Clin Cases. 2025 Apr 16;13(11):99748. doi: 10.12998/wjcc.v13.i11.99748.
3
Universal paramyxovirus vaccine design by stabilizing regions involved in structural transformation of the fusion protein.通过稳定参与融合蛋白结构转化的区域来设计通用副粘病毒疫苗。
Nat Commun. 2024 May 31;15(1):4629. doi: 10.1038/s41467-024-48059-w.
4
Animal Models for Henipavirus Research.动物模型在亨德拉尼帕病毒研究中的应用。
Viruses. 2023 Sep 22;15(10):1980. doi: 10.3390/v15101980.
5
Host-Pathogen Interactions Influencing Zoonotic Spillover Potential and Transmission in Humans.宿主-病原体相互作用影响人类中动物源性病原体溢出的潜力和传播。
Viruses. 2023 Feb 22;15(3):599. doi: 10.3390/v15030599.
6
Nipah Virus Bangladesh Infection Elicits Organ-Specific Innate and Inflammatory Responses in the Marmoset Model.尼帕病毒感染在狨猴模型中引起器官特异性先天和炎症反应。
J Infect Dis. 2023 Aug 31;228(5):604-614. doi: 10.1093/infdis/jiad053.
7
Evaluation of three rapid low-resource molecular tests for Nipah virus.三种针对尼帕病毒的快速低资源分子检测方法的评估
Front Microbiol. 2023 Feb 9;13:1101914. doi: 10.3389/fmicb.2022.1101914. eCollection 2022.
8
Genetic Diversity and Expanded Host Range of J Paramyxovirus Detected in Wild Small Mammals in China.在中国野生小型哺乳动物中检测到 J 副粘病毒的遗传多样性和扩大的宿主范围。
Viruses. 2022 Dec 23;15(1):49. doi: 10.3390/v15010049.
9
Knowledge, Attitudes, Risk Perception, Preparedness and Vaccine Intent of Health Care Providers towards the Nipah Virus in South India.印度南部医疗保健提供者对尼帕病毒的知识、态度、风险认知、防范准备及疫苗接种意愿
Trop Med Infect Dis. 2022 Apr 6;7(4):56. doi: 10.3390/tropicalmed7040056.
10
Henipaviruses-A constant threat to livestock and humans.亨德拉尼帕病毒——对家畜和人类的持续威胁。
PLoS Negl Trop Dis. 2022 Feb 18;16(2):e0010157. doi: 10.1371/journal.pntd.0010157. eCollection 2022 Feb.

本文引用的文献

1
A strategy to prevent future epidemics similar to the 2019-nCoV outbreak.一种预防未来类似于2019新型冠状病毒爆发的流行病的策略。
Biosaf Health. 2020 Mar;2(1):6-8. doi: 10.1016/j.bsheal.2020.01.003. Epub 2020 Feb 5.
2
Rational Vaccine Design in the Time of COVID-19.新冠疫情时期的合理疫苗设计。
Cell Host Microbe. 2020 May 13;27(5):695-698. doi: 10.1016/j.chom.2020.04.022.
3
SARS-CoV-2 productively infects human gut enterocytes.SARS-CoV-2 能有效地感染人类肠道肠细胞。
Science. 2020 Jul 3;369(6499):50-54. doi: 10.1126/science.abc1669. Epub 2020 May 1.
4
The COVID-19 vaccine development landscape.2019冠状病毒病疫苗的研发情况。
Nat Rev Drug Discov. 2020 May;19(5):305-306. doi: 10.1038/d41573-020-00073-5.
5
Ensuring global access to COVID-19 vaccines.确保全球能够获得新冠疫苗。
Lancet. 2020 May 2;395(10234):1405-1406. doi: 10.1016/S0140-6736(20)30763-7. Epub 2020 Mar 31.
6
Safety, tolerability, pharmacokinetics, and immunogenicity of a human monoclonal antibody targeting the G glycoprotein of henipaviruses in healthy adults: a first-in-human, randomised, controlled, phase 1 study.在健康成年人中靶向亨德拉尼帕病毒 G 糖蛋白的人源单克隆抗体的安全性、耐受性、药代动力学和免疫原性:首次人体、随机、对照、1 期研究。
Lancet Infect Dis. 2020 Apr;20(4):445-454. doi: 10.1016/S1473-3099(19)30634-6. Epub 2020 Feb 3.
7
A single-dose ChAdOx1-vectored vaccine provides complete protection against Nipah Bangladesh and Malaysia in Syrian golden hamsters.一剂 ChAdOx1 载体疫苗可在叙利亚金黄地鼠中提供针对孟加拉国和马来西亚尼帕病毒的完全保护。
PLoS Negl Trop Dis. 2019 Jun 6;13(6):e0007462. doi: 10.1371/journal.pntd.0007462. eCollection 2019 Jun.
8
Outbreak Investigation of Nipah Virus Disease in Kerala, India, 2018.2018 年印度喀拉拉邦尼帕病毒病疫情爆发调查。
J Infect Dis. 2019 May 24;219(12):1867-1878. doi: 10.1093/infdis/jiy612.
9
Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study.估算针对流行性传染病的疫苗开发成本:成本最小化研究。
Lancet Glob Health. 2018 Dec;6(12):e1386-e1396. doi: 10.1016/S2214-109X(18)30346-2. Epub 2018 Oct 18.